• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝门部胆管癌术后感染性并发症:单一西方中心经验。

Infectious complications after surgery for perihilar cholangiocarcinoma: A single Western center experience.

机构信息

Department of Surgery, Dentistry, Gynecology, and Pediatrics, Division of General and Hepato-Biliary Surgery, University of Verona, Italy.

Department of Surgery, Dentistry, Gynecology, and Pediatrics, Division of General and Hepato-Biliary Surgery, University of Verona, Italy.

出版信息

Surgery. 2022 Sep;172(3):813-820. doi: 10.1016/j.surg.2022.04.028. Epub 2022 May 24.

DOI:10.1016/j.surg.2022.04.028
PMID:35618490
Abstract

BACKGROUND

The aim of this study was to analyze the risk factors for surgical infectious complications and the outcomes of patients undergoing surgery for perihilar cholangiocarcinoma according to the microbiological examinations.

METHODS

Patients who underwent surgery for perihilar cholangiocarcinoma in the last decade were enrolled, and all clinical and microbiological data were collected from a retrospective monocentric database. Univariate and multivariate analyses were performed distinguishing patients who developed at least 1 surgical infectious complication (surgical site infections, acute bacterial cholangitis, bacteremia).

RESULTS

A total of 98 patients were included. Among patients who developed surgical infectious complications (51%), many preoperative characteristics were significantly more frequent: American Society of Anesthesiologists score ≥3 (P = .026), neutrophil-to-lymphocyte ratio ≥3.4 (P = .001), endoscopic sphincterotomy (P = .032), ≥2 biliary drainage procedures (P = .013), acute cholangitis (P = .012), multidrug resistant (P = .009), and ≥3 microorganisms' detection (P = .042); whereas during the postoperative period, surgical infectious complications were associated to increased incidence of intensive care unit readmission (P = .031), major complications (P < .001), posthepatectomy liver failure (P = .005), ascites (P = .008), biliary leakage (P = .008), 90-day readmission (P = .003), and prolonged length of hospital stay (P < .001). At the multivariate analysis 3 independent preoperative risk factors for surgical infectious complications were identified: neutrophil-to-lymphocyte ratio ≥3.4 (P = .004), endoscopic sphincterotomy (P = .009), and acute cholangitis (P = .013). The presence of multidrug-resistance in the perioperative biliary cultures was related to postoperative multidrug-resistant species from all cultures (P < .001) and organ/space and incisional-surgical site infections (P ≤ .044).

CONCLUSION

Infective complications after surgery for perihilar cholangiocarcinoma worsen the short-term outcomes. A careful microbiological surveillance should be carried out in all cases to prevent and promptly treat surgical infectious complications.

摘要

背景

本研究旨在分析根据微生物检查结果,行肝门部胆管癌切除术患者发生手术感染性并发症的危险因素和结局。

方法

回顾性分析过去十年间在我院行肝门部胆管癌切除术的患者的临床和微生物学数据。采用单因素和多因素分析方法,比较发生至少 1 种手术感染性并发症(手术部位感染、急性细菌性胆管炎、菌血症)与未发生手术感染性并发症患者的临床特征。

结果

共纳入 98 例患者。发生手术感染性并发症的患者(51%)中,许多术前特征更为常见:美国麻醉医师协会(ASA)评分≥3(P=0.026)、中性粒细胞与淋巴细胞比值≥3.4(P=0.001)、内镜下括约肌切开术(P=0.032)、≥2 次胆道引流术(P=0.013)、急性胆管炎(P=0.012)、多重耐药菌(P=0.009)和≥3 种微生物检测(P=0.042);术后,发生手术感染性并发症的患者 ICU 再入院率(P=0.031)、主要并发症(P<0.001)、肝切除术后肝功能衰竭(P=0.005)、腹水(P=0.008)、胆漏(P=0.008)、90 天再入院率(P=0.003)和住院时间延长(P<0.001)的发生率更高。多因素分析显示,术前 3 个独立的危险因素为中性粒细胞与淋巴细胞比值≥3.4(P=0.004)、内镜下括约肌切开术(P=0.009)和急性胆管炎(P=0.013)。术中胆道培养为多重耐药菌与术后所有培养物的多重耐药菌(P<0.001)和器官/腔隙及切口手术部位感染(P≤0.044)相关。

结论

肝门部胆管癌切除术后感染性并发症会加重短期结局。应仔细进行微生物监测,以预防和及时治疗手术感染性并发症。

相似文献

1
Infectious complications after surgery for perihilar cholangiocarcinoma: A single Western center experience.肝门部胆管癌术后感染性并发症:单一西方中心经验。
Surgery. 2022 Sep;172(3):813-820. doi: 10.1016/j.surg.2022.04.028. Epub 2022 May 24.
2
Predictive Factors and Microbial Spectrum for Infectious Complications after Hepatectomy with Cholangiojejunostomy in Perihilar Cholangiocarcinoma.肝门部胆管癌胆肠吻合术后感染并发症的预测因素和微生物谱。
Surg Infect (Larchmt). 2020 Apr;21(3):275-283. doi: 10.1089/sur.2019.199. Epub 2019 Nov 11.
3
Liver resection for perihilar cholangiocarcinoma: Impact of biliary drainage failure on postoperative outcome. Results of an Italian multicenter study.肝切除术治疗肝门部胆管癌:胆道引流失败对术后结果的影响。一项意大利多中心研究的结果。
Surgery. 2021 Aug;170(2):383-389. doi: 10.1016/j.surg.2021.01.021. Epub 2021 Feb 20.
4
Biliary Decompression in Perihilar Cholangiocarcinoma Improves Survival: A Single-Center Retrospective Analysis.肝门部胆管癌行胆系减压术可改善生存:单中心回顾性分析。
Dig Dis Sci. 2019 Feb;64(2):561-569. doi: 10.1007/s10620-018-5277-z. Epub 2018 Sep 20.
5
A Comparison of Preoperative Biliary Drainage Methods for Perihilar Cholangiocarcinoma: Endoscopic versus Percutaneous Transhepatic Biliary Drainage.肝门部胆管癌术前胆道引流方法的比较:内镜引流与经皮肝穿刺胆道引流
Gut Liver. 2015 Nov 23;9(6):791-9. doi: 10.5009/gnl14243.
6
Preoperative biliary drainage versus direct surgery for perihilar cholangiocarcinoma: A retrospective study at a single center.肝门部胆管癌术前胆道引流与直接手术的比较:单中心回顾性研究
Biosci Trends. 2017 Jul 24;11(3):319-325. doi: 10.5582/bst.2017.01107. Epub 2017 May 22.
7
Preoperative Cholangitis and Future Liver Remnant Volume Determine the Risk of Liver Failure in Patients Undergoing Resection for Hilar Cholangiocarcinoma.术前胆管炎和未来肝残余体积决定肝门部胆管癌切除术患者肝衰竭的风险。
J Am Coll Surg. 2016 Jul;223(1):87-97. doi: 10.1016/j.jamcollsurg.2016.01.060. Epub 2016 Feb 13.
8
Postoperative infectious complications caused by multidrug-resistant pathogens in patients undergoing major hepatectomy with extrahepatic bile duct resection.肝外胆管切除的大肝叶切除术后由多重耐药病原体引起的感染性并发症。
Surgery. 2020 Jun;167(6):950-956. doi: 10.1016/j.surg.2020.02.015. Epub 2020 Apr 14.
9
Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications.164 例疑诊肝门部胆管癌患者术前内镜鼻胆管引流:疗效的回顾性研究及与并发症相关的危险因素分析。
Ann Surg. 2013 Jan;257(1):121-7. doi: 10.1097/SLA.0b013e318262b2e9.
10
One hundred two consecutive hepatobiliary resections for perihilar cholangiocarcinoma with zero mortality.对肝门部胆管癌进行的连续102例肝胆切除术,死亡率为零。
Ann Surg. 2006 Aug;244(2):240-7. doi: 10.1097/01.sla.0000217605.66519.38.

引用本文的文献

1
Operative and Oncological Outcomes of Vascular Resection and Reconstruction for Perihilar Cholangiocarcinoma.肝门部胆管癌血管切除重建的手术及肿瘤学结局
Ann Surg Oncol. 2025 Sep 13. doi: 10.1245/s10434-025-18137-4.
2
Can We Lower the Burden of Antimicrobial Resistance (AMR) in Heavily Immunocompromised Patients? A Narrative Review and Call to Action.我们能否降低重症免疫功能低下患者的抗菌药物耐药性(AMR)负担?一项叙述性综述及行动呼吁。
Infect Dis Ther. 2025 Aug 7. doi: 10.1007/s40121-025-01204-4.
3
Unfavorable microbiological impact of directly duodenal biliary drainage in patients with perihilar obstruction: a preliminary report.
肝门部梗阻患者直接十二指肠胆道引流的不良微生物学影响:初步报告
Front Surg. 2025 Jul 10;12:1538676. doi: 10.3389/fsurg.2025.1538676. eCollection 2025.
4
Focusing on the Immune Cells: Recent Advances in Immunotherapy for Biliary Tract Cancer.聚焦免疫细胞:胆管癌免疫治疗的最新进展
Cancer Manag Res. 2024 Jul 29;16:941-963. doi: 10.2147/CMAR.S474348. eCollection 2024.
5
A novel use of the comprehensive complication index in perihilar cholangiocarcinoma surgery.综合并发症指数在肝门部胆管癌手术中的新应用。
Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):139-142. doi: 10.21037/hbsn-23-585. Epub 2023 Dec 28.
6
Liver abscess caused by Clostridium perfringens after left hepatic trisectionectomy for perihilar cholangiocarcinoma: a case report.肝门部胆管癌左半肝切除术后产气荚膜梭菌引起的肝脓肿:一例报告
Surg Case Rep. 2023 Jun 19;9(1):111. doi: 10.1186/s40792-023-01687-8.